Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Tubulin polymerization-IN-90

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T218801 Copy Product Info
🥰Excellent
Tubulin polymerization-IN-90 is an inhibitor of tubulin polymerization. It disrupts tubulin assembly by binding to the nocodazole binding site on β-tubulin. This compound induces the release of extracellular vesicles marked by the tetraspanin CD63 and stimulates cells to release IL-8. Tubulin polymerization-IN-90 also reduces cancer cell viability and is utilized in research on cancers such as acute T-cell lymphoblastic leukemia.

Tubulin polymerization-IN-90

Cas No. 3006800-41-2
Pack SizePriceUSA StockGlobal StockQuantity
10 mgInquiry10-14 weeks10-14 weeks
50 mgInquiry10-14 weeks10-14 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Tubulin polymerization-IN-90 is an inhibitor of tubulin polymerization. It disrupts tubulin assembly by binding to the nocodazole binding site on β-tubulin. This compound induces the release of extracellular vesicles marked by the tetraspanin CD63 and stimulates cells to release IL-8. Tubulin polymerization-IN-90 also reduces cancer cell viability and is utilized in research on cancers such as acute T-cell lymphoblastic leukemia.
In vitro
Tubulin polymerization-IN-90 (Compound 39) significantly enhances the activity of the CD63 extracellular vesicle release reporter gene in CD63 Tluc-CD9 EmGFP THP-1 cells at a concentration of 10 μM over 48 hours. Tubulin polymerization-IN-90 demonstrates a dose-dependent inhibition of tubulin polymerization at concentrations ranging from 1-10 μM. It inhibits the viability of wild-type CEM T cells with an IC50 of 0.09 μM and CEM-178 TUBB mutant cells with an IC50 of 0.11 μM, when used at 0.001-0.1 μM for 20 hours. Additionally, at 20 μM, it induces significant release of human interleukin-8 (IL-8) from human peripheral blood mononuclear cells (hPBMCs).
Chemical Properties
Molecular Weight354.43
FormulaC21H14N4S
Cas No.3006800-41-2
SmilesN1=CC(=CC(=C1)N2N=NC(=C2)C=3C=CC=C4C=CC=CC43)C=5SC=CC5
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
µL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: Tubulin polymerization-IN-90 in vitro | Tubulin polymerization-IN-90 formula | Tubulin polymerization-IN-90 molecular weight